Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 118469-15-1 | MDL No. : | MFCD00792439 |
Formula : | C8H7FN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | IWDUKSHNFODGKM-UHFFFAOYSA-N |
M.W : | 150.15 | Pubchem ID : | 2775375 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 41.02 |
TPSA : | 28.68 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.8 cm/s |
Log Po/w (iLOGP) : | 1.39 |
Log Po/w (XLOGP3) : | 1.99 |
Log Po/w (WLOGP) : | 2.43 |
Log Po/w (MLOGP) : | 1.75 |
Log Po/w (SILICOS-IT) : | 2.9 |
Consensus Log Po/w : | 2.09 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.63 |
Solubility : | 0.352 mg/ml ; 0.00234 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.22 |
Solubility : | 0.908 mg/ml ; 0.00605 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.56 |
Solubility : | 0.0415 mg/ml ; 0.000277 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.71 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With indium; acetic acid In ethyl acetate for 4 h; Reflux; Inert atmosphere | General procedure: 2-Nitroaniline derivative (1 mmol) was added to a mixture of indium powder (574 mg, 5.0 mmol for 2-nitroaniline, 918 mg 8.0 mmol for 1,2-dinitroarene), and acetic acid (0.572 mL, 10 mmol) in ethyl acetate (2 mL), followed by the addition of trimethyl orthoester (2.0 mmol) in ethyl acetate (3 mL for 2-nitroaniline; 8 mL for 1,2-dinitroarene). The reaction mixture was stirred at reflux under a nitrogen atmosphere. After the reaction was completed, the reaction mixture was diluted with ethyl acetate (30 mL), filtered through Celite, poured into 10percent NaHCO3 (30 mL), and then extracted with ethyl acetate (30 mL.x.3). The combined organic extracts were dried over MgSO4, filtered, and concentrated. The residue was eluted with ethyl acetate/hexane (v/v=10/90) for 2-phenylbenzimidazole derivatives or methanol/dichloromethane (v/v=1/99) for 2-methylbenzimidazole derivatives through a silica gel column to give the corresponding benzimidazoles. The structures of the benzimidazoles were characterized by 1H NMR, 13C NMR, FTIR, and GC-MS, and were mostly known compounds. HRMS data were reported in addition for unknown compounds. |
[ 39811-07-9 ]
(5-Fluoro-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.89
[ 885280-34-2 ]
6-Fluoro-1H-benzo[d]imidazole-2-carbaldehyde
Similarity: 0.77
[ 1008360-84-6 ]
5-Bromo-6-fluoro-1H-benzo[d]imidazole
Similarity: 0.77
[ 6758-34-5 ]
(5-(Trifluoromethyl)-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.70
[ 39811-07-9 ]
(5-Fluoro-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.89
[ 885280-34-2 ]
6-Fluoro-1H-benzo[d]imidazole-2-carbaldehyde
Similarity: 0.77
[ 1008360-84-6 ]
5-Bromo-6-fluoro-1H-benzo[d]imidazole
Similarity: 0.77
[ 5805-57-2 ]
(1H-Benzo[d]imidazol-2-yl)methanamine
Similarity: 0.75